Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

被引:74
作者
Pang, Jing [1 ]
Poulter, Elissa B. [1 ]
Bell, Damon A. [1 ,2 ,3 ]
Bates, Timothy R. [1 ,2 ]
Jefferson, Vicki-Lee [1 ]
Hillis, Graham S. [1 ,4 ]
Schultz, Carl J. [1 ,4 ]
Watts, Gerald F. [1 ,2 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia
[2] Royal Perth Hosp, Cardiovasc Med, Lipid Disorders Clin, Perth, WA, Australia
[3] Royal Perth Hosp, PathWest Lab Med WA, Dept Clin Biochem, Perth, WA, Australia
[4] Royal Perth Hosp, Dept Cardiol, Perth, WA, Australia
关键词
Familial hypercholesterolemia; Screening; Coronary care unit; Prevalence; RISK-FACTORS; HEART-DISEASE; MYOCARDIAL-INFARCTION; GENETIC-ANALYSIS; YOUNG-PATIENTS; LIPID-LEVELS; PREVALENCE; MANAGEMENT; HYPERLIPIDEMIA; DIAGNOSIS;
D O I
10.1016/j.jacl.2015.07.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Familial hypercholesterolemia (FH) is the most common dominantly inherited cause of premature coronary artery disease (CAD). However, the diagnosis of FH in patients who have premature CAD in hospital settings is under-recognized, this also represents a missed opportunity for screening their close family members and implementing primary prevention. OBJECTIVE: To investigate the point prevalence of FH in a coronary care unit (CCU) among patients with early-onset CAD. METHODS: The prevalence of FH, based on modified phenotypic Dutch Lipid Clinic Network Criteria, and the spectrum of associated CAD risk factors, were investigated in a CCU setting. Data were collected on 175 coronary care patients with onset of CAD at age <60 years. RESULTS: The prevalence of probable/definite FM was 14.3% (95% confidence interval, 9.0%-19.5%); 46.3% of the patients gave a family history of premature CAD and 20.6% had an untreated low-density lipoprotein cholesterol >5.0 mmol/L. Diabetes, hypertension, obesity, and smoking were common and equally prevalent in patients with and without FR. CONCLUSIONS: FH is relatively frequent among patients with a history of early-onset CAD in the CCU. Every effort should be made to detect FH in these patients and to initiate cascade testing of available family members to prevent the development of CAD in those who may be unaware that they also have the condition. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 36 条
[1]   Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia [J].
Ademi, Zanfina ;
Watts, Gerald F. ;
Pang, Jing ;
Sijbrands, Eric J. G. ;
van Bockxmeer, Frank M. ;
O'Leary, Peter ;
Geelhoed, Elizabeth ;
Liew, Danny .
JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (04) :390-400
[2]   Detection of familial hypercholesterolaemia: A major treatment gap in preventative cardiology [J].
Bates, Timothy R. ;
Burnett, John R. ;
van Bockxmeer, Frank M. ;
Hamilton, Sandra ;
Arnolda, Leonard ;
Watts, Gerald F. .
HEART LUNG AND CIRCULATION, 2008, 17 (05) :411-413
[3]   Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: Can we do better? Analysis of results obtained during the past two decades in 1669 French subjects [J].
Beliard, S. ;
Carreau, V. ;
Carrie, A. ;
Giral, P. ;
Duchene, E. ;
Farnier, M. ;
Ferrieres, J. ;
Fredenrich, A. ;
Krempf, M. ;
Luc, G. ;
Moulin, P. ;
Bruckert, E. .
ATHEROSCLEROSIS, 2014, 234 (01) :136-141
[4]   Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience [J].
Bell, Damon A. ;
Pang, Jing ;
Burrows, Sally ;
Bates, Timothy R. ;
van Bockxmeer, Frank M. ;
Hooper, Amanda J. ;
O'Leary, Peter ;
Burnett, John R. ;
Watts, Gerald F. .
ATHEROSCLEROSIS, 2015, 239 (01) :93-100
[5]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964
[6]   Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia [J].
Civeira, Fernando ;
Ros, Emilio ;
Jarauta, Estibaliz ;
Plana, Nuria ;
Zambon, Daniel ;
Puzo, Jose ;
Martinez de Esteban, Juan P. ;
Ferrando, Juan ;
Zabala, Sergio ;
Almagro, Fatima ;
Gimeno, Jose A. ;
Masana, Luis ;
Pocovi, Miguel .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (09) :1187-1193
[7]   Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology [J].
De Backer, Guy ;
Besseling, Joost ;
Chapman, John ;
Hovingh, G. Kees ;
Kastelein, John J. P. ;
Kotseva, Kornelia ;
Ray, Kausik ;
Reiner, Zeljko ;
Wood, David ;
De Bacquer, Dirk .
ATHEROSCLEROSIS, 2015, 241 (01) :169-175
[8]   Familial hypercholesterolaemia is underdiagnosed after AMI [J].
Dorsch, MF ;
Lawrance, RA ;
Durham, NP ;
Hall, AS .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7278) :111-111
[9]   Familial Hypercholesterolemia: An Under-recognized but Significant Concern in Cardiology Practice [J].
Foody, JoAnne M. .
CLINICAL CARDIOLOGY, 2014, 37 (02) :119-125
[10]   The molecular basis of familial hypercholesterolemia in The Netherlands [J].
Fouchier, SW ;
Defesche, JC ;
Umans-Eckenhausen, MAW ;
Kastelein, JJP .
HUMAN GENETICS, 2001, 109 (06) :602-615